Kaopectate Max Peppermint Flavor Anti Diarrheal Liquid
NDC Package 55505-200-36

11-digit billing NDC: 55505020036

Package Information

This product is approaching its end of marketing date. An upcoming end of marketing date means the product has been delisted but will remain in the NDC database until the end of marketing date is reached. In most cases, the FDA advises firms to use the expiration date of the last lot produced as the end marketing date, reflecting the possibility that the product may still be available even after manufacturing has stopped.

Kaopectate Max Peppermint Flavor Anti Diarrheal (bismuth subsalicylate) liquids is uses relievestraveler’s diarrheadiarrheaupset stomach due to overindulgence in food and drink, including:heartburnindigestionnauseagasbelchingfullness. This formulation utilizes a liquid delivery system. Marketed by Kramer Laboratories, this product is identified by NDC 55505-200 and is authorized under FDA application M008.

Identification & Billing

NDC Package Code
55505-200-36
Package Description
236 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
55505020036
RxNorm Crosswalk
  • RxCUI: 1043048 - Kaopectate Extra Strength 525 MG in 15 mL Oral Suspension, Reformulated Aug 2006
  • RxCUI: 1043048 - bismuth subsalicylate 35 MG/ML Oral Suspension [Kaopectate Reformulated Aug 2006]
  • RxCUI: 1043048 - Kaopectate 525 MG per 15 ML Oral Suspension, Reformulated Aug 2006
  • RxCUI: 1043048 - Kaopectate Reformulated Aug 2006 35 MG/ML Oral Suspension
  • RxCUI: 308763 - bismuth subsalicylate 1050 MG in 30 mL Oral Suspension

Clinical Specifications

Proprietary Name
Kaopectate Max Peppermint Flavor Anti Diarrheal
Non-Proprietary Name
Bismuth Subsalicylate
Substance Name
Bismuth Subsalicylate
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Uses relievestraveler’s diarrheadiarrheaupset stomach due to overindulgence in food and drink, including:heartburnindigestionnauseagasbelchingfullness

Regulatory & Marketing

Labeler Name
Kramer Laboratories
Product Type
Human Otc Drug
FDA Application #
M008
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
11-01-2020
End Marketing Date
01-01-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55505-200-36 identifies a specific commercial package of 236 ml in 1 bottle of Kaopectate Max Peppermint Flavor Anti Diarrheal, a human over the counter drug labeled by Kramer Laboratories. This liquid is formulated for oral use and contains bismuth subsalicylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kramer Laboratories on November 01, 2020.

How is this Kramer Laboratories product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55505020036. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55505-200-36
11-Digit CMS (5-4-2)
55505-0200-36

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.